Switzerland-based Novartis has named Elizabeth Barrett as the head of its oncology franchise based at the group's headquarters in Switzerland, it is reported today.

Barrett is to succeed Bruno Strigini who has held various leadership positions in the pharmaceutical industry and in the commercial sector. She most recently served Pfizer, leading its oncology business but has held several roles with the pharma giant including president, Europe, president North America, speciality care and US president of oncology. Prior to her time with Pfizer, Barrett held roles with Cephalon and Johnson & Johnson.

Vas Narasimhan, chief executive officer at Novartis, said, 'Liz is a highly accomplished and recognised oncology and people leader with an impressive record of building successful business organisations in the US. She has been instrumental in creating new commercial models, driving innovation in close partnership with research and development and leveraging business development opportunities. Her long-time commercial pharma industry experience, marketing skills and perspectives make Liz a great fit to further develop our oncology business.'